Perceived Susceptibility to Mental Disorders among Marijuana Smokers Attending a Tertiary Institution

IF 0.2 4区医学 Q4 MEDICINE, GENERAL & INTERNAL West Indian Medical Journal Pub Date : 2017-10-26 DOI:10.7727/WIMJ.2017.193

N. Albarus, P. Whitehorne-Smith, W. Abel

引用次数: 0

Abstract

Objective: This exploratory qualitative study sought to investigate the question of ‘how do marijuana smokers at a tertiary institution perceive their susceptibility to mental illness?’. Methods: The study utilized an instrumental case study design. Convenience and snowball sampling techniques were employed to garner participants. Inclusion criteria were that the participants had to be enrolled at a tertiary institution and had smoked at least an average of one spliff of marijuana per week for at least one year. Data collection comprised 12 in-depth interviews with the participants (six male and six female), direct observation, and content analysis of Jamaica’s amended Dangerous Drugs Act of 2015. Results: Emergent were themes of personal experience, social environment and low-risk perception for mental illness. Conclusion: Risk perception for mental illness was low. Participants perceived marijuana use as a viable coping strategy and demonstrated limited understanding of the negative effects of smoking marijuana.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

就读于高等院校的大麻吸烟者对精神疾病的易感性

目的：这项探索性的定性研究试图调查“在高等院校吸食大麻的人如何看待他们对精神疾病的易感性？”。方法：本研究采用工具性案例研究设计。采用方便和滚雪球抽样技术来吸引参与者。纳入标准是，参与者必须在高等教育机构注册，并且在至少一年的时间里平均每周至少抽一支大麻。数据收集包括对参与者（6男6女）的12次深入访谈、直接观察和对牙买加2015年修订的《危险药物法》的内容分析。结果：突发事件的主题是个人经历、社会环境和对精神疾病的低风险认知。结论：对精神疾病的风险认知较低。参与者认为使用大麻是一种可行的应对策略，对吸食大麻的负面影响了解有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

West Indian Medical Journal 医学-医学：内科

CiteScore

0.20

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： The Journal is international in scope, with author and editorial contributions from across the globe. The focus is on clinical and epidemiological aspects of tropical and infectious diseases, new and re-emerging infections, chronic non-communicable diseases, and medical conditions prevalent in the Latin America-Caribbean region, and of significance to global health, especially in developing countries. The Journal covers all medical disciplines, as well as basic and translational research elucidating the pathophysiologic basis of diseases or focussing on new therapeutic approaches, and publishes original scientific research, reviews, case reports, brief communications, letters, commentaries and medical images. The Journal publishes four to six issues and four supplements annually. English is the language of publication but Abstracts are also duplicated in Spanish. Most of the articles are submitted at the authors’ initiative, but some are solicited by the Editor-in-Chief. Unless expressly stated, the Editorial Board does not accept responsibility for authors’ opinions. All papers on submission are reviewed by a subcommittee. Those deemed worthy for review are sent to two or three reviewers (one of the three might be a statistician if necessary). The returned papers with reviewer comments are reviewed by the Editor-in-Chief. Papers may be rejected, accepted or sent back to authors for revision. Resubmitted papers from authors are reviewed by the Editor-in-Chief and may be sent back to reviewers or a final decision made by Editor-in-Chief. The decision of the Editorial Board is final with regards to rejected articles. Rejected articles will not be returned to the authors. The editorial subcommittee has the right to return sub-standard manuscripts to the authors, rather than passing them on to the reviewers. This implies outright rejection of the manuscript.